The Advanced Research Projects Agency for Health (ARPA-H) supports transformative research to drive biomedical and health breakthroughs ranging from molecular to societal to provide transformative health solutions for all.| ARPA-H
Chapel Hill-based University of North Carolina Lineberger Comprehensive Cancer Center has been awarded up to $28 million to develop an adaptive clinical trial targeting metastatic breast cancer. The trial is part of the Advanced Research Projects Agency for Health’s Advanced Analysis for Precision Cancer Therapy program, also called ADAPT. Other ADAPT awardees and their trial […]| Becker's Hospital Review | Healthcare News & Analysis
UNC Lineberger will lead the development of a next-generation clinical trial for metastatic breast cancer. The new trial design will adapt treatment plans in near real-time by analyzing changes in each patient’s cancer and matching it to the most promising therapy.| UNC Lineberger